Literature DB >> 18392782

Sacral nerve stimulation for faecal incontinence.

J M O'Riordan1, C F Healy, D McLoughlin, M Cassidy, A E Brannigan, P R O'Connell.   

Abstract

BACKGROUND: Faecal incontinence resulting from obstetric injury is a socially disabling condition with a significant impact on quality of life. Sacral nerve stimulation (SNS) is a relatively new treatment modality, which offers patients a potential for improved continence.
METHODS: We reviewed our initial experience of SNS in 14 patients (mean age 54 years, range 30-72) with faecal incontinence from January 2006 to June 2007. Background demographics, past medical and obstetric history, anal manometry, endoanal ultrasound and pudendal nerve studies were recorded on all patients. All patients who had permanent SNS implants inserted had pre and post operative questionnaires consisting of the Wexner Continence Score and the Rockwood and SF-36 Quality of Life Indices.
RESULTS: Out of 14 patients, 13 had incontinence related to obstetric injuries while one was related to a cauda equina syndrome. All patients had a test procedure consisting of placement of temporary electrodes and a 2-week trial of external SNS. Ten patients noted a significant improvement in their continence and these 10 patients subsequently had a permanent SNS device implanted with an overall significant improvement in continence (P < 0.001) and quality of life (P < 0.01). There were no immediate postoperative complications and one late failure consisting of a lead fracture, which was replaced successfully. Four (29%) patients did not have a significant benefit from temporary SNS and two of these patients subsequently had a colostomy.
CONCLUSIONS: SNS offers improvement in continence and quality of life in patients with faecal incontinence whose only other option might otherwise be a permanent colostomy.

Entities:  

Mesh:

Year:  2008        PMID: 18392782     DOI: 10.1007/s11845-008-0145-z

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  20 in total

1.  Fecal Incontinence Quality of Life Scale: quality of life instrument for patients with fecal incontinence.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  2000-01       Impact factor: 4.585

Review 2.  Fecal incontinence.

Authors:  R D Madoff; J G Williams; P F Caushaj
Journal:  N Engl J Med       Date:  1992-04-09       Impact factor: 91.245

3.  Rectal volume tolerability and anal pressures in patients with fecal incontinence treated with sacral nerve stimulation.

Authors:  Hanne B Michelsen; Steen Buntzen; Klaus Krogh; Søren Laurberg
Journal:  Dis Colon Rectum       Date:  2006-07       Impact factor: 4.585

4.  Outcome and cost analysis of sacral nerve stimulation for faecal incontinence.

Authors:  F H Hetzer; A Bieler; D Hahnloser; F Löhlein; P-A Clavien; N Demartines
Journal:  Br J Surg       Date:  2006-11       Impact factor: 6.939

5.  Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence.

Authors:  K E Matzel; U Stadelmaier; M Hohenfellner; F P Gall
Journal:  Lancet       Date:  1995-10-28       Impact factor: 79.321

Review 6.  Etiology and management of fecal incontinence.

Authors:  J M Jorge; S D Wexner
Journal:  Dis Colon Rectum       Date:  1993-01       Impact factor: 4.585

7.  Sacral nerve neuromodulation for the treatment of lower bowel motility disorders.

Authors:  Nicholas J Kenefick
Journal:  Ann R Coll Surg Engl       Date:  2006-11       Impact factor: 1.891

8.  Effect of sacral nerve stimulation on autonomic nerve function.

Authors:  N J Kenefick; A Emmanuel; R J Nicholls; M A Kamm
Journal:  Br J Surg       Date:  2003-10       Impact factor: 6.939

9.  The safety and efficacy of the artificial bowel sphincter for fecal incontinence: results from a multicenter cohort study.

Authors:  W Douglas Wong; Susan M Congliosi; Michael P Spencer; Marvin L Corman; Patrick Tan; Frank G Opelka; Marcus Burnstein; Juan J Nogueras; H Randolph Bailey; Jose Manuel Devesa; Robert D Fry; Burt Cagir; Elisa Birnbaum; James W Fleshman; Mallory A Lawrence; W Donald Buie; John Heine; Peter S Edelstein; Sharon Gregorcyk; Paul Antoine Lehur; Francis Michot; P Terry Phang; David J Schoetz; Fabio Potenti; Josephine Y Tsai
Journal:  Dis Colon Rectum       Date:  2002-09       Impact factor: 4.585

10.  Sacral neuromodulation in patients with faecal incontinence: results of the first 100 permanent implantations.

Authors:  J Melenhorst; S M Koch; O Uludag; W G van Gemert; C G Baeten
Journal:  Colorectal Dis       Date:  2007-05-17       Impact factor: 3.788

View more
  2 in total

1.  Adverse events of sacral neuromodulation for fecal incontinence reported to the federal drug administration.

Authors:  Klaus Bielefeldt
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

2.  Sacral neuromodulation for bowel dysfunction: a consensus statement from the Italian group.

Authors:  E Falletto; E Ganio; G Naldini; C Ratto; D F Altomare
Journal:  Tech Coloproctol       Date:  2013-04-06       Impact factor: 3.781

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.